学术探索
学术期刊
新闻热点
数据分析
智能评审

Review article: monitoring of immunomodulators in inflammatory bowel disease

被引：52
作者：
Aberra, FN [1 ]
Lichtenstein, GR [1 ]
机构：
[1] Univ Penn, Hosp Univ Penn, Sch Med,Div Gastroenterol, Dept Med,Ctr Inflammatory Bowel Dis, Philadelphia, PA 19104 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2005年 / 21卷 / 04期
关键词：
D O I：
10.1111/j.1365-2036.2005.02343.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The armamentarium of medications for the treatment of inflammatory bowel disease is growing and becoming more complicated to use. Immunomodulators are a class of medications that have found a niche for the treatment of Crohn's disease and ulcerative colitis. Because of the mounting supporting evidence for efficacy, the most commonly-used immunomodulators are azathioprine, mercaptopurine, methotrexate and ciclosporin. These medications are being used more often due to their steroid-sparing and potentially surgery-sparing effects. Immunomodulators are also known for a significant side-effect profile and require careful monitoring. This review provides the latest information for clinicians on efficacy, side-effects, dosing and monitoring of these medications for treatment of inflammatory bowel disease.
引用
收藏
页码：307 / 319
页数：13
相关论文
共 125 条
  • [81] Oren R, 1997, AM J GASTROENTEROL, V92, P2203
  • [82] Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial
    Oren, R
    Arber, N
    Odes, S
    Moshkowitz, M
    Keter, D
    Pomeranz, I
    Ron, Y
    Reisfeld, I
    Broide, E
    Lavy, A
    Fich, A
    Eliakim, R
    Patz, J
    Bardan, E
    Villa, Y
    Gilat, T
    [J]. GASTROENTEROLOGY, 1996, 110 (05) : 1416 - 1421
  • [83] Ortiz Z, 1998, J RHEUMATOL, V25, P36
  • [84] Ortiz Z., 2000, COCHRANE DB SYST REV
  • [85] Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms
    Otterness, D
    Szumlanski, C
    Lennard, L
    Klemetsdal, B
    Aarbakke, J
    ParkHah, JO
    Iven, H
    Schmiegelow, K
    Branum, E
    OBrien, J
    Weinshilboum, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) : 60 - 73
  • [86] Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission
    Paoluzi, OA
    Pica, R
    Marcheggiano, A
    Crispino, P
    Iacopini, F
    Iannoni, C
    Rivera, M
    Paoluzi, P
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1751 - 1759
  • [87] AZATHIOPRINE AND 6-MERCAPTOPURINE IN CROHN DISEASE - A METAANALYSIS
    PEARSON, DC
    MAY, GR
    FICK, GH
    SUTHERLAND, LR
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (02) : 132 - 142
  • [88] PEARSON DC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000067
  • [89] Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy:: Possible role of concomitant methotrexate
    Pettersson, B
    Almer, S
    Albertioni, F
    Söderhäll, S
    Peterson, C
    [J]. THERAPEUTIC DRUG MONITORING, 2002, 24 (03) : 351 - 358
  • [90] TREATMENT OF CROHNS-DISEASE WITH 6-MERCAPTOPURINE - A LONG-TERM, RANDOMIZED, DOUBLE-BLIND-STUDY
    PRESENT, DH
    KORELITZ, BI
    WISCH, N
    GLASS, JL
    SACHAR, DB
    PASTERNACK, BS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (18) : 981 - 987
45678910111213